Money
Briefing: Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch
Strategic angle: Tandem Diabetes Care outlines strategic changes aimed at improving profitability and launching innovative products.
editorial-staff
1 min read
Updated 20 days ago
Tandem Diabetes Care is shifting its operational focus towards pharmacy distribution as part of a broader strategy to improve profitability.
The company has set a target of achieving a 65% gross margin by the year 2026, indicating a significant emphasis on financial performance.
Additionally, Tandem plans to introduce the Mobi Tubeless device in 2026, which may impact its product lineup and market positioning.